Evidence map›Paper›PMID 2526846›Full record

ArticleThe Journal of experimental medicine1989

Alternative membrane forms of Fc gamma RIII(CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions.

J V Ravetch, B Perussia

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 1989. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 188 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
188citing papers in PubMed, 1 pooled it
14.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

188 citing papers in PubMed, 1 synthesis or guideline pooled it, 571 citations in OpenAlex.

  1. Pooled it
  2. Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032.Clinical cancer research : an official journal of the American Association for Cancer Research · 2021
    Trial
  3. Trial
  4. Analysis of Fcγ receptor IIIa and IIa polymorphisms: lack of correlation with outcome in trastuzumab-treated breast cancer patients.Clinical cancer research : an official journal of the American Association for Cancer Research · 2012
    Trial
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Pitfalls When Determining HNA-1 Genotypes and Finding Novel Alleles.International journal of molecular sciences · 2024
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Multifaceted roles of Fcγ receptors in COVID-19 and vaccine responses.American journal of translational research · 2023
    Review

128 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

J V RavetchDeWitt Wallace Research Laboratory, Sloan-Kettering Institute, New York, New York 10021.
B Perussia
Kettering University · US

Funding

RECEPTORS FOR IMMUNOGLOBULIN G ON LEUKOCYTESR01CA037155 · NCI · WISTAR INSTITUTE · PI PERUSSIA, BICE · 1985 to 1997
–
ACTIVATION OF NON-MHC-RESTRICTED CYTOTOXIC LYMPHOCYTESR01CA045284 · NCI · WISTAR INSTITUTE · PI PERUSSIA, BICE · 1987 to 1998
–
STUDY OF FC RECEPTOR GENES: MACROPHAGES AND LYMPHOCYTESR01GM039256 · NIGMS · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI RAVETCH, JEFFREY VICTOR · 1988 to 1992
–
NCI NIH HHS CA-37155NCI NIH HHS CA-45284NIGMS NIH HHS GM-39256
6 · The paper itself

Abstract

A low affinity receptor for IgG immune complexes, Fc gamma RIII(CD16), is expressed on human NK cells as an integral membrane glycoprotein anchored through a transmembrane peptide; on polymorphonuclear neutrophils (PMN) the receptor is anchored through a phosphatidylinositol (PI) linkage. The protein on NK cells has a molecular mass 6-10 kD larger than that on PMN, and, unlike the latter, is resistant to PI-specific phospholipase C (PI-PLC). Fc gamma RIII(CD16) transcripts isolated from PMN and NK cells of single donors revealed multiple single nucleotide differences, one of which converts an in frame UGA termination codon to a CGA codon. The resulting open reading frame encodes a longer cytoplasmic domain for Fc gamma RIII(CD16) in NK cells, contributing to its transmembrane anchor. Two nearly identical, linked genes that encode these transcripts have been cloned for Fc gamma RIII(CD16), one of which (III-1) is allelic for NA-1 and NA-2. The allelic sites have been mapped to two single nucleotides in the extracellular domain. These genes are transcribed in a cell type-specific fashion to generate the alternatively anchored forms of this receptor.

Indexed as

Amino Acid SequenceAntigens, DifferentiationBase SequenceCloning, MolecularDNAGenesGlycoside HydrolasesHumansKiller Cells, NaturalMembrane GlycoproteinsMolecular Sequence DataNeutrophilsOligonucleotide ProbesPeptide Chain Termination, TranslationalPhosphatidylinositolsReceptors, FcAntigens, DifferentiationDNAglycanaseGlycoside HydrolasesMembrane GlycoproteinsOligonucleotide ProbesPhosphatidylinositolsReceptors, FcReceptors, IgGRNA, MessengerType C Phospholipases

Identifiers

PMID2526846
PMCPMC2189395
OpenAlexW2182452189

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.